Elemer Piros, Managing Director & Senior Research Analyst at Roth Capital Markets discusses the psychedelic market.
Piros believes that the market is very large. with nearly 4 million Americans suffering from treatment-resistant depression. "There's more than enough room for more than one market participant – each with billions of dollars in market share," says Piros.